In vivo monitoring of singlet oxygen using delayed chemiluminescence during photodynamic therapy

Journal of Biomedical Optics

Volumn 12, Issue 1, 2007, Pages

  Wei, Yanchun ^a   Zhou, Jing ^a   Xing, Da ^a   Chen, Qun ^a,b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chemiluminescence (CL); Photodynamic therapy; Singlet oxygen; Skin

Indexed keywords

CHEMILUMINESCENCE; CYTOTOXICITY; LIGHT INTERFERENCE; OPTICAL SENSORS; OXYGEN;

IN VIVO MONITORING; SINGLET OXYGEN;

PHOTODYNAMIC THERAPY;

SINGLET OXYGEN; TUMOR MARKER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMOLUMINESCENCE; EQUIPMENT; EQUIPMENT DESIGN; EVALUATION; INSTRUMENTATION; METABOLISM; METHODOLOGY; MOUSE; PHOTOCHEMOTHERAPY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SKIN; SKIN TUMOR;

ANIMALS; CHEMILUMINESCENT MEASUREMENTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SINGLET OXYGEN; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247643197     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2437151     Document Type: Article

References (29)

1. K. Jiang, Y. Cheng, and S. M. Wu, "The photodynamic therapy of tumor," Laser J. 25(1), 77-99 (2004).
2. J. M. Wu, J. W. Xiong, and H. Xiao, "The photodynamic therapy used in the treatment of tumor," Laser J. 24(1), 70-73 (2003).
3. S. B. Brown, E. A. Brown, and I. Walker, "The present and future role of photodynamic therapy in cancer treatment," Lancet Oncol. 5, 497-508 (2004). (Pubitemid 39069400)
4. C. S. Foote, "Definition of type I and type II photosensitized oxidation," Photochem. Photobiol. 54, 659-661 (1991).
5. J. Moan, Q. Peng, R. Sorensen, V. Iani, and J. M. Nesland, "The biophysical foundations of photodynamic therapy," Endoscopy 30, 387-391 (1998). (Pubitemid 28353592)
6. W. M. Sharman, C. M. Allen, and J. E. van Lier, "Photodynamic therapeutics: basic principles and clinical application," Drug Discovery Today 4(11), 507-517 (1999). (Pubitemid 29497854)
7. B. W. McIlroy, T. S. Mann, J. S. Dysart, and B. C. Wilson, "The effects of oxygenation and photosensitizer substrate binding on the use of fluorescence photobleaching as a dose metric for photodynamic therapy," Vib. Spectrosc. 28, 25-35 (2002). (Pubitemid 34291393)
8. J. C. Finlay, S. Mitra, M. S. Patterson, and T. H. Foster, "Pho-tobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms," Phys. Med. Biol. 49, 4837-4860 (2004). (Pubitemid 39489928)
9. L. W. Ma, S. Bagdonas, and J. Moan, "The photosensitizing effect of the photoproduct of protoporphyrin IX," J. Photochem. Photobiol., B 60, 108-113 (2001). (Pubitemid 32747241)
10. M. J. Niedre, M. S. Patterson, and B. C. Wilson, "Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo," Photochem. Photobiol. 75, 382-391 (2002).
11. M. J. Niedre, A. J. Secord, M. S. Patterson, and B. C. Wilson, "In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy," Cancer Res. 63, 7986-7994 (2003). (Pubitemid 37466737)
12. C. Schweitzer and R. Schmidt, "Physical mechanisms of generation and deactivation of singlet oxygen," Chem. Rev. (Washington, D.C.) 103, 1685-1757 (2003).
13. J. W. Snyder, I. Zebger, Z. Gao, L. Poulsen, P. K. Frederiksen, E. Skovsen, S. P. McIlroy, M. Klinger, L. K. Andersen, and P. R. Ogilby, "Singlet oxygen microscope: from phase-separated polymers to single biological cells," Acc. Chem. Res. 37, 894-901 (2004).
14. K. Teranishi and T. Nishiguchi, "Cyclodextrin-bound 6-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-ones with fluorescein as green chemiluminescent probes for superoxide anions," Anal. Bio-chem. 325, 185-195 (2004). (Pubitemid 38134355)
15. X. H. Li, G. X. Zhang, H. M. Ma, D. Q. Zhang, J. Li, and D. B. Zhu, "4,5-dimethylthio-40-[2-(9-anthryloxy)ethylthio]tetrathiafulvalene, a highly selective and sensitive chemiluminescence probe for singlet oxygen," J. Am. Chem. Soc. 126, 11543-11548 (2004). (Pubitemid 39244970)
16. M. Hao, D. Xing, Q. Chen, and J. Wang, "A high sensitivity detection method of singlet oxygen and superoxide anion," Chin. Chem. Lett. 15(6), 679-682 (2004). (Pubitemid 38857724)
17. Y. F. Qin, D. Xing, J. Zhou, S. M. Luo, and Q. Chen, "Feasibility of using fluoresceinyl cypridina luciferin analog in a novel chemilumi-nescence method for real-time photodynamic therapy dosimetry," Photochem. Photobiol. 81, 1534-1538 (2005). (Pubitemid 43035868)
18. M. Nakano, K. Sugioka, Y. Ushuima, and T. Goto, "Chemilumines-cence probe with cypridina luciferin analog estimating the ability of human granulocytes to generate O2-," Anal. Biochem. 159, 363-369 (1986).
19. Y. H. He, D. Xing, S. Tan, Y. H. Tang, and K. Ueda, "In vivo sonolu-minescence imaging with the assistance of FCLA," Phys. Med. Biol. 47, 1535-1541 (2002). (Pubitemid 34567835)
20. L. K. Verna, D. Chen, G. Schluter, and G. M. Williams, "Inhibition by singlet oxygen quenchers of oxidative damage to DNA produced in cultured cells by exposure to a quinolone antibiotic and ultraviolet A irradiation," Cell Biol. Toxicol. 14, 237-242 (1998). (Pubitemid 28283909)
21. Y. X. Wu and D. Xing, "Permeating efficiency and localization of fcla and hpd through membrane of lung, cancer cell," Acta Laser Biology Sinica 14(4), 287-291 (2005).
22. K. K. L. Yee, K. C. Soo, B. H. Bay, and M. Olivo, "A comparison of protoprophyrin IX and protoporphyrin IX dimethyl ester as photosen-sitizer in poorly differentiated human nasopharyngeal carcinoma cells," Photochem. Photobiol. 76(6), 678-682 (2002).
23. J. Zhou, D. Xing, and Q. Chen, "Enhancement of fluoresceinyl cyp-ridina luciferin analog chemiluminescence by human serum albumin for singlet oxygen detection," Photochem. Photobiol. 82(4), 1058-1064 (2006). (Pubitemid 44450192)
24. N. S. Soukos, S. Som, A. D. Abernethy, K. Ruggiero, J. Dunham, C. Lee, A. G. Doukas, and J. M. Goodson, "Phototargeting oral black-pigmented bacteria," Antimicrob. Agents Chemother. 49, 1391-1396 (2005). (Pubitemid 40463367)
25. M. J. Niedre, C. S. Yu, M. S. Patterson, and B. C. Wilson, "Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid," Br. J. Cancer 92, 298-304 (2005). (Pubitemid 40343145)
26. H. W. Wang, M. E. Putt, M. J. Emanuele, D. B. Shin, E. Glatstein, A. G. Yodh, and T. M. Busch, "Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome," Cancer Res. 64, 7553-7561 (2004). (Pubitemid 39372100)
27. H. J. C. M. Sterenborg, J. W. de Wolf, M. Koning, B. Kruijt, A. van den Heuvel, and D. J. Robinson, "Phosphorescence-fluorescence ratio imaging for monitoring the oxygen status during photodynamic therapy," Opt. Express 12(9), 1873-1878 (2004).
28. L. A. Boere, D. J. Robinson, H. S. de Bruijn, J. van den Boogert, H. W. Tilanus, H. J. C. M. Sterenborg, and R. W. F. de Bruin, "Monitoring in situ dosimetry and protoporphyrin IX fluorescence pho-tobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy," Photochem. Photobiol. 78(3), 271-277 (2003).
29. H. Sakurai, H. Yasui, Y. Yamada, H. Nishimura, and M. Shigemoto, "Detection of reactive oxygen species in the skin of live mice and rats exposed to UVA light: a research review on chemiluminescence and trials for UVA protection," Photochem. Photobiol. Sci. 4(9), 715-720 (2005). (Pubitemid 41367022)